Literature DB >> 3959754

Analgesic effect of metoclopramide and its mechanism.

S Ramaswamy, J S Bapna.   

Abstract

Metoclopramide produced a significant analgesic effect when tested by both acetic acid induced writhing and hot plate test. This effect was reduced by naloxone suggesting opioid involvement. Further, bromocriptine which inhibits the release of PRL attenuated the effect of metoclopramide indicating that this drug could act by releasing PRL. The unaltered analgesic effect of metoclopramide by yohimbine reveals that alpha-2 adrenoceptors may not be involved in this action.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3959754     DOI: 10.1016/0024-3205(86)90421-2

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  5 in total

1.  The effect of metoclopramide on the absorption of oral controlled release morphine.

Authors:  A R Manara; M P Shelly; K Quinn; G R Park
Journal:  Br J Clin Pharmacol       Date:  1988-04       Impact factor: 4.335

2.  [Oral papaverine prevents morphine-induced constipation without interfering with analgesia achieved with oral morphine].

Authors:  I Jurna; K Jurna; J Baldauf; M Zenz
Journal:  Schmerz       Date:  1996-02-15       Impact factor: 1.107

3.  Single pretreatment of remifentanil may reduce pain after propofol and rocuronium injection in rapid sequence induction.

Authors:  Yoon Ji Choi; Han Seok Park; Han Lee; Seung Zhoo Yoon
Journal:  Korean J Anesthesiol       Date:  2012-11-16

4.  Remifentanil prevents withdrawal movements caused by intravenous injection of rocuronium.

Authors:  Byung In Choi; Seung Ho Choi; Yang-Sik Shin; Sung Jin Lee; Kyung Bong Yoon; Seo Kyung Shin; Ki-Young Lee
Journal:  Yonsei Med J       Date:  2008-04-30       Impact factor: 2.759

5.  Adding metoclopramide to lidocaine for intravenous regional anesthesia in trauma patients.

Authors:  Mohammadreza Safavi; Azim Honarmand; Alireza Yazdanpanah
Journal:  Adv Biomed Res       Date:  2014-01-24
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.